Grip strength and mortality: 38 cohorts, 1.9 million people, one number to carry
Pooling 38 cohorts with 1,907,580 participants and 63,087 deaths, stronger handgrip carried a mortality hazard ratio of 0.69 against weaker grip, and 0.60 in women against 0.69 in men. A second meta-analysis of 48 studies and 3,135,473 people found the cardiovascular curve bends both ways.
goodWell supported, with the usual caveats about effect size.Revised
Thirty seconds of squeezing, repeated across millions of people, and it sorts them into groups that die at different rates. What it does not do is explain itself.
There is a measurement in gerontology that takes about thirty seconds, needs no laboratory, and predicts mortality about as well as blood pressure does. You squeeze a dynamometer as hard as you can, twice, and the best of the two is recorded. Across 38 cohorts, it is the sort of number that changes how a doctor looks at you.
What the pooled cohorts found
The 2018 meta-analysis pulled together 38 studies, 1,907,580 participants and 63,087 deaths, all from apparently healthy populations. Compared with weaker muscular strength, higher handgrip strength carried an all-cause mortality hazard ratio of 0.69 (95% CI 0.64–0.74).
The sex split is the interesting part: 0.60 (0.51–0.69) in women against 0.69 (0.62–0.77) in men, both at P<0.001. And it was not only the hand: adults with higher strength on a knee-extension test had a 14 per cent lower risk of death, hazard ratio 0.86 (0.80–0.93). The authors’ conclusion is careful — associated with lower mortality regardless of age and follow-up period.
What the thresholds look like
A 2022 review of 48 studies and 3,135,473 participants (49.6 per cent women, aged 35 to 85) went a step further and asked whether the relationship has a shape rather than a yes-or-no answer.
For all-cause mortality, higher grip kept reducing risk across the 26–50 kg range. For cardiovascular mortality, the curve was U-shaped: a significant reduction between 16 and 33 kg (I²=77.4 per cent), then a near-linear further reduction from 24 to 40 kg in a separate analysis (I²=79.7 per cent). The heterogeneity is large in both cases, which is the polite word for “the studies do not agree precisely”.
What these numbers do not show
They do not show that squeezing harder makes you live longer. Every study here is observational, and grip strength is not randomly assigned — it travels with disease burden, nutrition, income, muscle mass, and whether somebody still walks to the shops. The direction of causation is genuinely unresolved.
They also do not show a threshold above which more is better. The cardiovascular curve is U-shaped in one analysis and near-linear in another, from the same literature, which is the honest way of saying that the shape is not settled. And the mortality endpoint is not a version of grip strength: it is deaths from all causes, which bundles cardiovascular disease, cancer, falls, infection and everything else into one number.
What you can carry away from this is narrow and useful: grip strength is a genuinely prognostic measure, it is nearly free to measure, and it is one of the few simple numbers that behaves the same way in women and men. Everything past that sentence is inference.
Sources
- Arch Phys Med Rehabil 2018 — Muscular strength as a predictor of all-cause mortality in an apparently healthy population: a systematic review and meta-analysis of data from approximately 2 million men and women (PMID 29425700)
- Ageing Res Rev 2022 — Thresholds of handgrip strength for all-cause, cancer, and cardiovascular mortality: a systematic review with meta-analysis (PMID 36332759)